Literature DB >> 3668517

Effects of chronic melatonin administration on GABA and diazepam binding in rat brain.

L P Niles1, D S Pickering, M A Arciszewski.   

Abstract

In order to determine whether the in vitro ability of the pineal indoleamine hormone, melatonin, to modulate binding at the GABA-benzodiazepine receptor complex is operative in vivo we have examined the effects of chronic melatonin administration on 3H-GABA and 3H-diazepam binding in rat brain. Melatonin was injected daily in increasing doses for three weeks and animals were sacrificed at 2 or 26 hours after the final injection. A melatonin-induced enhancement of 3H-GABA binding was observed in both single-point and saturation binding experiments. Scatchard analysis of 3H-diazepam binding revealed a melatonin-induced increase in binding affinity at 26 hours in the forebrain and at 2 hours in the cerebellum with no significant changes in binding site concentration. These findings are consistent with the proposal that melatonin's psychopharmacological effects are due at least in part to its ability to enhance central GABAergic transmission by modulating GABA receptor activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3668517     DOI: 10.1007/bf01252513

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  18 in total

Review 1.  Possible involvement of GABA in the central actions of benzodiazepines.

Authors:  W Haefely; A Kulcsár; H Möhler; L Pieri; P Polc; R Schaffner
Journal:  Adv Biochem Psychopharmacol       Date:  1975

2.  [3H] melatonin binding in membrane and cytosol fractions from rat and calf brain.

Authors:  L P Niles
Journal:  J Pineal Res       Date:  1987       Impact factor: 13.007

Review 3.  Psychoactive agents and GABA-receptors.

Authors:  F V DeFeudis
Journal:  Pharmacol Res Commun       Date:  1983-01

4.  On the effect of melatonin upon human brain. Its possible therapeutic implications.

Authors:  F Antón-Tay; J L Díaz; A Fernández-Guardiola
Journal:  Life Sci I       Date:  1971-08-01

5.  In vitro effects of melatonin on [3H]muscimol binding in rat brain.

Authors:  F M Coloma; L P Niles
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1984       Impact factor: 5.067

6.  Antiepileptic effects of melatonin in the pinealectomized Mongolian gerbil.

Authors:  P K Rudeen; R C Philo; S K Symmes
Journal:  Epilepsia       Date:  1980-04       Impact factor: 5.864

7.  Chronic clonazepam administration induces benzodiazepine receptor subsensitivity.

Authors:  J N Crawley; P J Marangos; J Stivers; F K Goodwin
Journal:  Neuropharmacology       Date:  1982-01       Impact factor: 5.250

8.  Chloride-dependent stimulation of GABA and benzodiazepine receptor binding by pentobarbital.

Authors:  T Asano; N Ogasawara
Journal:  Brain Res       Date:  1981-11-23       Impact factor: 3.252

9.  Chronic benzodiazepine treatment increases [3H]muscimol binding in mouse brain.

Authors:  P J Marangos; J N Crawley
Journal:  Neuropharmacology       Date:  1982-01       Impact factor: 5.250

10.  Rapid changes in GABA binding induced by stress in different areas of the rat brain.

Authors:  G Biggio; M G Corda; A Concas; G Demontis; Z Rossetti; G L Gessa
Journal:  Brain Res       Date:  1981-12-21       Impact factor: 3.252

View more
  11 in total

Review 1.  Chronobiology of limbic seizures: Potential mechanisms and prospects of chronotherapy for mesial temporal lobe epilepsy.

Authors:  Daniel Leite Góes Gitai; Tiago Gomes de Andrade; Ygor Daniel Ramos Dos Santos; Sahithi Attaluri; Ashok K Shetty
Journal:  Neurosci Biobehav Rev       Date:  2019-01-07       Impact factor: 8.989

2.  Exogenous melatonin reproduces the effects of short day lengths on hippocampal function in male white-footed mice, Peromyscus leucopus.

Authors:  J C Walton; Z Chen; J B Travers; R J Nelson
Journal:  Neuroscience       Date:  2013-06-24       Impact factor: 3.590

3.  Antidepressant- and anxiolytic effects of the novel melatonin agonist Neu-P11 in rodent models.

Authors:  Shao-wen Tian; Moshe Laudon; Li Han; Jun Gao; Fu-lian Huang; Yu-feng Yang; Hai-feng Deng
Journal:  Acta Pharmacol Sin       Date:  2010-06-28       Impact factor: 6.150

4.  Melatonin supplementation for the treatment of infantile spasms: protocol for a randomised placebo-controlled triple-blind trial.

Authors:  Yulin Sun; Weiwei Feng; Jian Chen; Miao Liu; Xiuyu Shi; Jing Wang; Liping Zou; Tao Xu; Guang Yang
Journal:  BMJ Open       Date:  2022-07-04       Impact factor: 3.006

5.  Evaluation of the role of chronic daily melatonin administration and pinealectomy on penicillin-induced focal epileptiform activity and spectral analysis of ECoG in rats: an in vivo electrophysiological study.

Authors:  Mehmet Yildirim; Selcen Aydin-Abidin; Ismail Abidin; Metehan Akca; Sinan Canpolat; Ali Cansu
Journal:  Neurochem Res       Date:  2013-05-14       Impact factor: 3.996

Review 6.  Melatonin as add-on treatment for epilepsy.

Authors:  Francesco Brigo; Stanley C Igwe; Alessandra Del Felice
Journal:  Cochrane Database Syst Rev       Date:  2016-08-11

Review 7.  Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders.

Authors:  Moshe Laudon; Anat Frydman-Marom
Journal:  Int J Mol Sci       Date:  2014-09-09       Impact factor: 5.923

Review 8.  Chronopharmacology of anti-convulsive therapy.

Authors:  Sriram Ramgopal; Sigride Thome-Souza; Tobias Loddenkemper
Journal:  Curr Neurol Neurosci Rep       Date:  2013-04       Impact factor: 5.081

Review 9.  Neuroinflammation and the Immune-Kynurenine Pathway in Anxiety Disorders.

Authors:  Yong-Ku Kim; Sang Won Jeon
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

Review 10.  Insights into Potential Targets for Therapeutic Intervention in Epilepsy.

Authors:  Cecilia Zavala-Tecuapetla; Manola Cuellar-Herrera; Hiram Luna-Munguia
Journal:  Int J Mol Sci       Date:  2020-11-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.